Van ECK Associates Corp lowered its stake in Chemed Corporation (NYSE:CHE – Free Report) by 9.2% during the 2nd quarter, Holdings Channel reports. The firm owned 13,437 shares of the company’s stock after selling 1,364 shares during the quarter. Van ECK Associates Corp’s holdings in Chemed were worth $6,258,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. Commonwealth Equity Services LLC lifted its holdings in shares of Chemed by 3.1% in the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock valued at $314,000 after acquiring an additional 22 shares during the last quarter. Cim LLC lifted its position in shares of Chemed by 1.1% during the third quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after purchasing an additional 24 shares during the last quarter. Eukles Asset Management lifted its holdings in Chemed by 0.4% during the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock valued at $2,591,000 after buying an additional 25 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Chemed by 65.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock valued at $38,000 after purchasing an additional 32 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Chemed by 9.4% in the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock worth $153,000 after buying an additional 35 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the stock. Oppenheimer upped their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Royal Bank Of Canada boosted their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $530.75.
Chemed Trading Up 2.0%
Shares of Chemed stock opened at $525.49 on Thursday. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The stock’s 50 day simple moving average is $514.08 and its 200-day simple moving average is $450.97. The stock has a market cap of $6.87 billion, a P/E ratio of 26.39, a P/E/G ratio of 1.95 and a beta of 0.51. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00.
Chemed (NYSE:CHE – Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same period last year, the company earned $4.27 EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.
Chemed Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a $0.70 dividend. The ex-dividend date is Monday, August 17th. This is a positive change from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is currently 14.06%.
Insiders Place Their Bets
In related news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. This represents a 2.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is owned by company insiders.
Chemed Company Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Further Reading
- Five stocks we like better than Chemed
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
